What is Custom Protein Services?
Custom protein manufacturing is the most efficient approach in life sciences and plays a significant role in advanced healthcare. Custom proteins are employed in a variety of research, biotechnology, and medical applications. The bespoke protein manufacturing services market is predicted to rise due to increased investment in the field of life sciences. A custom protein is a modified form of a gene-encoded protein. It's employed in the synthesis of massive amounts of protein, which is then used to make therapeutic commercial items. The industry is predicted to rise due to increased government initiatives and investment in the field of life sciences.
Attributes | Details |
---|
Study Period | 2017-2027 |
Base Year | 2021 |
Unit | Value (USD Million) |
Key Companies Profiled | GenScript Biotech Corporation (United States), Agilent Technologies Inc. (United States), Thermo Fisher Scientific Inc. (United States), Takara Bio, Inc. (Japan), Bio-Rad Laboratories Inc. (United States), Lonza (Switzerland), Promega Corporation (United States), New England Biolabs (United States), Oxford Expression Technologies Ltd. (United Kingdom), ProteoGenix (United States) and Peak Proteins Ltd. (United Kingdom) |
The study covers a detailed analysis segmented by key business segments i.e. by type (Protein Codon Optimization, Protein Gene Synthesis, Cell Culture and Fermentation, Protein Expression and Purification and Other) and major geographies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Custom Protein Services market throughout the predicted period.
The competition is expected to become even more intense in the years to come due to the entry of several new players in the market. To help clients improve their revenue shares in the market, this research study provides an in-depth analysis of the markets competitive landscape and offers information on the products offered by various leading companies. Additionally, this Custom Protein Services market report suggests strategies that Players can follow and highlights key areas they should focus on, in order to take maximum benefits of growth opportunities.
The report offers several leading Players, some of them are GenScript Biotech Corporation (United States), Agilent Technologies Inc. (United States), Thermo Fisher Scientific Inc. (United States), Takara Bio, Inc. (Japan), Bio-Rad Laboratories Inc. (United States), Lonza (Switzerland), Promega Corporation (United States), New England Biolabs (United States), Oxford Expression Technologies Ltd. (United Kingdom), ProteoGenix (United States) and Peak Proteins Ltd. (United Kingdom).
Market Overview:
May 2022, Meridian Bioscience, Inc. announced that it has acquired, through its subsidiary Meridian Life Science, Inc., substantially all of the assets of EUPROTEIN Inc. Recombinant monoclonal antibodies, human and other mammalian proteins, and bespoke development and production of high-quality bioresearch reagents are all offered by EUPROTEIN Inc. Meridian will be able to extend its recombinant capabilities while also accelerating the development of novel immunological reagents in its pipeline.
The players present in the market focus on new launches to expand their product portfolio through molecular diagnostics and improved life sciences solutions. Also, they focus on mergers and acquisitions to enhance their global presence.
Custom Protein Services Market Dynamics:
Attributes | Details |
---|
Growth Drivers | - Increasing Demand for Protein Biologics
- Growth in the life Science and Biopharmaceutical Industries
|
Major Trends | - Increasing Research and Development and Product Launches
|
Restraints | - High Cost of Protein Expression Reagents and Instruments
|
Road Blocks / Challenges | - Stringent Regulatory Factors
|
Gaps & Opportunities | - Growth Opportunities in Untapped Markets
|
Key highlights of the Global Custom Protein Services market Study:
CAGR of the market during the forecast period 2021-2027
In-depth information on growth factors that will accelerate the Custom Protein Services market in next few years.
Detailed Insights on futuristic trends and changing consumer behavior
Forecast of the Global Custom Protein Services market size and its contribution to the parent market by type, application and by country.
A broad view of customer demand
Uncover markets competitive landscape and in-depth information on various Players
Comprehensive information about factors that will challenge the growth of Custom Protein Services Players
Transformation and Important Triggers:
Business transformation has taken hold across the broad corporate landscape due to the confluence of several important triggers, including:
A tipping point in globalization
A major slowdown in Western economies
Significant shifts in technology and cost structure
The challenges of regulatory compliance
New forms of competition developing
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Custom Protein Services market.
In order to reach an exhaustive list of functional and relevant players, various industry classification standards are closely followed such as NAICS, ICB, and SIC to penetrate deep into important geographies by players, and a thorough validation test is conducted to reach the most relevant players for survey in Custom Protein Services market.
In order to make a priority list sorting is done based on revenue generated based on the latest reporting, using paid databases such as Factiva, Bloomberg, etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment> by targeting key target audience that includes Hospitals, Medical Device Manufacturers, Market Research and Consulting Firms, Healthcare Service Providers, Medical Research Institutes, BioPharma Companies and Governmental Bodies.
This helps us to gather the data for the players revenue, operating cycle and expense, profit along with product or service growth, etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that include Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases, etc.